Circulating Tumor Cells Market Size, Trends, Analysis, and Outlook By Technology (CTC Detection & Enrichment Methods (Immunocapture, Size-based Separation, Density-based Separation, Combined Methods), CTC Direct Detection Methods (SERS, Microscopy, Others), CTC Analysis)), By Application (Clinical/ Liquid Biopsy (Risk Assessment, Screening and Monitoring), Research, Cancer Stem Cell & Tumorogenesis Research, Drug/Therapy Development), By Product (Kits & Reagents, Blood Collection Tubes, Devices or Systems), By Specimen (Blood, Bone Marrow, Others), By End-user (Research and Academic Institutes, Hospital and Clinics, Diagnostic Centers), by Region, Country, Segment, and Companies, 2024-2030
The global Circulating Tumor Cells market size is poised to register 12.42% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Circulating Tumor Cells market across By Technology (CTC Detection & Enrichment Methods (Immunocapture, Size-based Separation, Density-based Separation, Combined Methods), CTC Direct Detection Methods (SERS, Microscopy, Others), CTC Analysis)), By Application (Clinical/ Liquid Biopsy (Risk Assessment, Screening and Monitoring), Research, Cancer Stem Cell & Tumorogenesis Research, Drug/Therapy Development), By Product (Kits & Reagents, Blood Collection Tubes, Devices or Systems), By Specimen (Blood, Bone Marrow, Others), By End-user (Research and Academic Institutes, Hospital and Clinics, Diagnostic Centers).
The circulating tumor cells market is experiencing rapid growth, influenced by various trends and driving forces in 2024 and beyond. Circulating tumor cells (CTCs), which are cancer cells shed into the bloodstream from primary or metastatic tumors, hold immense potential as a non-invasive biomarker for cancer diagnosis, prognosis, and treatment monitoring. Market growth is driven by increasing cancer incidence worldwide, leading to a growing demand for non-invasive diagnostic and monitoring tools. Moreover, advancements in technologies for CTC isolation, enumeration, and molecular characterization are enhancing the sensitivity and specificity of CTC-based assays, enabling more accurate detection and characterization of cancer cells in peripheral blood samples. Additionally, the growing focus on personalized medicine and precision oncology is fueling the development of companion diagnostic tests based on CTC analysis, facilitating targeted therapy selection and treatment optimization for cancer patients. Furthermore, collaborations between academic research institutions, biotechnology companies, and healthcare providers are driving innovation and shaping industry dynamics in the circulating tumor cells market.
Circulating Tumor Cells Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Circulating Tumor Cells market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Circulating Tumor Cells survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Circulating Tumor Cells industry.
Key market trends defining the global Circulating Tumor Cells demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Circulating Tumor Cells Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Circulating Tumor Cells industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Circulating Tumor Cells companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Circulating Tumor Cells industry
Leading Circulating Tumor Cells companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Circulating Tumor Cells companies.
Circulating Tumor Cells Market Study- Strategic Analysis Review
The Circulating Tumor Cells market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Circulating Tumor Cells industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Circulating Tumor Cells Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Circulating Tumor Cells Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Circulating Tumor Cells market segments. Similarly, Strong end-user demand is encouraging Canadian Circulating Tumor Cells companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Circulating Tumor Cells market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Circulating Tumor Cells Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Circulating Tumor Cells industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Circulating Tumor Cells market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Circulating Tumor Cells Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Circulating Tumor Cells in Asia Pacific. In particular, China, India, and South East Asian Circulating Tumor Cells markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Circulating Tumor Cells Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Circulating Tumor Cells Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Circulating Tumor Cells market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Circulating Tumor Cells.
Circulating Tumor Cells Market Company Profiles
The global Circulating Tumor Cells market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AVIVA Biosciences, BIOCEPT, Inc., BioCEP Ltd., BioFluidica, Biolidics Limited, Bio-Techne Corporation, Canopus Bioscience Ltd., Creativ MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio-One International GmbH, Ikonisys, Inc., IVDiagnostics, Inc., LineaRx, Inc. (Vitatex, Inc.), LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision for Medicine, QIAGEN, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, , ,
Recent Circulating Tumor Cells Market Developments
The global Circulating Tumor Cells market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Circulating Tumor Cells Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Technology
CTC Detection & Enrichment Methods
-Immunocapture (Label-based)
-Size-based Separation (Label-free)
-Density-based Separation (Label-free)
-Combined Methods
CTC Direct Detection Methods
-SERS
-Microscopy
-Others
CTC Analysis
By Application
Clinical/ Liquid Biopsy
-Risk Assessment
-Screening and Monitoring
Research
-Cancer Stem Cell & Tumorogenesis Research
-Drug/Therapy Development
By Product
Kits & Reagents
Blood Collection Tubes
Devices or Systems
By Specimen
Blood
Bone Marrow
Others
By End-user
Research and Academic Institutes
Hospital and Clinics
Diagnostic Centers
Geographical Segmentation:
AVIVA Biosciences
BIOCEPT, Inc.
BioCEP Ltd.
BioFluidica
Biolidics Limited
Bio-Techne Corporation
Canopus Bioscience Ltd.
Creativ MicroTech, Inc.
Epic Sciences
Fluxion Biosciences, Inc.
Greiner Bio-One International GmbH
Ikonisys, Inc.
IVDiagnostics, Inc.
LineaRx, Inc. (Vitatex, Inc.)
LungLife AI, Inc.
Menarini Silicon Biosystems
Miltenyi Biotec
Precision for Medicine
QIAGEN
Rarecells Diagnostics
ScreenCell
STEMCELL Technologies, Inc.
Sysmex Corporation
Formats Available: Excel, PDF, and PPT
The circulating tumor cells market is experiencing rapid growth, influenced by various trends and driving forces in 2024 and beyond. Circulating tumor cells (CTCs), which are cancer cells shed into the bloodstream from primary or metastatic tumors, hold immense potential as a non-invasive biomarker for cancer diagnosis, prognosis, and treatment monitoring. Market growth is driven by increasing cancer incidence worldwide, leading to a growing demand for non-invasive diagnostic and monitoring tools. Moreover, advancements in technologies for CTC isolation, enumeration, and molecular characterization are enhancing the sensitivity and specificity of CTC-based assays, enabling more accurate detection and characterization of cancer cells in peripheral blood samples. Additionally, the growing focus on personalized medicine and precision oncology is fueling the development of companion diagnostic tests based on CTC analysis, facilitating targeted therapy selection and treatment optimization for cancer patients. Furthermore, collaborations between academic research institutions, biotechnology companies, and healthcare providers are driving innovation and shaping industry dynamics in the circulating tumor cells market.
Circulating Tumor Cells Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Circulating Tumor Cells market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Circulating Tumor Cells survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Circulating Tumor Cells industry.
Key market trends defining the global Circulating Tumor Cells demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Circulating Tumor Cells Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Circulating Tumor Cells industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Circulating Tumor Cells companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Circulating Tumor Cells industry
Leading Circulating Tumor Cells companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Circulating Tumor Cells companies.
Circulating Tumor Cells Market Study- Strategic Analysis Review
The Circulating Tumor Cells market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Circulating Tumor Cells industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Circulating Tumor Cells Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Circulating Tumor Cells Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Circulating Tumor Cells market segments. Similarly, Strong end-user demand is encouraging Canadian Circulating Tumor Cells companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Circulating Tumor Cells market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Circulating Tumor Cells Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Circulating Tumor Cells industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Circulating Tumor Cells market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Circulating Tumor Cells Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Circulating Tumor Cells in Asia Pacific. In particular, China, India, and South East Asian Circulating Tumor Cells markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Circulating Tumor Cells Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Circulating Tumor Cells Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Circulating Tumor Cells market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Circulating Tumor Cells.
Circulating Tumor Cells Market Company Profiles
The global Circulating Tumor Cells market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AVIVA Biosciences, BIOCEPT, Inc., BioCEP Ltd., BioFluidica, Biolidics Limited, Bio-Techne Corporation, Canopus Bioscience Ltd., Creativ MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio-One International GmbH, Ikonisys, Inc., IVDiagnostics, Inc., LineaRx, Inc. (Vitatex, Inc.), LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision for Medicine, QIAGEN, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, , ,
Recent Circulating Tumor Cells Market Developments
The global Circulating Tumor Cells market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Circulating Tumor Cells Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Technology
CTC Detection & Enrichment Methods
-Immunocapture (Label-based)
-Size-based Separation (Label-free)
-Density-based Separation (Label-free)
-Combined Methods
CTC Direct Detection Methods
-SERS
-Microscopy
-Others
CTC Analysis
By Application
Clinical/ Liquid Biopsy
-Risk Assessment
-Screening and Monitoring
Research
-Cancer Stem Cell & Tumorogenesis Research
-Drug/Therapy Development
By Product
Kits & Reagents
Blood Collection Tubes
Devices or Systems
By Specimen
Blood
Bone Marrow
Others
By End-user
Research and Academic Institutes
Hospital and Clinics
Diagnostic Centers
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AVIVA Biosciences
BIOCEPT, Inc.
BioCEP Ltd.
BioFluidica
Biolidics Limited
Bio-Techne Corporation
Canopus Bioscience Ltd.
Creativ MicroTech, Inc.
Epic Sciences
Fluxion Biosciences, Inc.
Greiner Bio-One International GmbH
Ikonisys, Inc.
IVDiagnostics, Inc.
LineaRx, Inc. (Vitatex, Inc.)
LungLife AI, Inc.
Menarini Silicon Biosystems
Miltenyi Biotec
Precision for Medicine
QIAGEN
Rarecells Diagnostics
ScreenCell
STEMCELL Technologies, Inc.
Sysmex Corporation
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Circulating Tumor Cells Market Overview and Key Findings, 2024
1.2 Circulating Tumor Cells Market Size and Growth Outlook, 2021- 2030
1.3 Circulating Tumor Cells Market Growth Opportunities to 2030
1.4 Key Circulating Tumor Cells Market Trends and Challenges
1.4.1 Circulating Tumor Cells Market Drivers and Trends
1.4.2 Circulating Tumor Cells Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Circulating Tumor Cells Companies
2. CIRCULATING TUMOR CELLS MARKET SIZE OUTLOOK TO 2030
2.1 Circulating Tumor Cells Market Size Outlook, USD Million, 2021- 2030
2.2 Circulating Tumor Cells Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CIRCULATING TUMOR CELLS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CIRCULATING TUMOR CELLS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Technology
CTC Detection & Enrichment Methods
-Immunocapture (Label-based)
-Size-based Separation (Label-free)
-Density-based Separation (Label-free)
-Combined Methods
CTC Direct Detection Methods
-SERS
-Microscopy
-Others
CTC Analysis
By Application
Clinical/ Liquid Biopsy
-Risk Assessment
-Screening and Monitoring
Research
-Cancer Stem Cell & Tumorogenesis Research
-Drug/Therapy Development
By Product
Kits & Reagents
Blood Collection Tubes
Devices or Systems
By Specimen
Blood
Bone Marrow
Others
By End-user
Research and Academic Institutes
Hospital and Clinics
Diagnostic Centers
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Circulating Tumor Cells Market, 2025
5.2 Asia Pacific Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Circulating Tumor Cells Market, 2025
5.5 Europe Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.6 Europe Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Circulating Tumor Cells Market, 2025
5.8 North America Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.9 North America Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Circulating Tumor Cells Market, 2025
5.11 South America Pacific Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.12 South America Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Circulating Tumor Cells Market, 2025
5.14 Middle East Africa Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Circulating Tumor Cells Market Size Outlook and Revenue Growth Forecasts
6.2 US Circulating Tumor Cells Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Circulating Tumor Cells Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Circulating Tumor Cells Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Circulating Tumor Cells Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Circulating Tumor Cells Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Circulating Tumor Cells Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Circulating Tumor Cells Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Circulating Tumor Cells Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Circulating Tumor Cells Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Circulating Tumor Cells Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Circulating Tumor Cells Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Circulating Tumor Cells Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Circulating Tumor Cells Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Circulating Tumor Cells Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Circulating Tumor Cells Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Circulating Tumor Cells Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Circulating Tumor Cells Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Circulating Tumor Cells Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Circulating Tumor Cells Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Circulating Tumor Cells Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Circulating Tumor Cells Industry Drivers and Opportunities
7. CIRCULATING TUMOR CELLS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CIRCULATING TUMOR CELLS COMPANY PROFILES
8.1 Profiles of Leading Circulating Tumor Cells Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AVIVA Biosciences
BIOCEPT, Inc.
BioCEP Ltd.
BioFluidica
Biolidics Limited
Bio-Techne Corporation
Canopus Bioscience Ltd.
Creativ MicroTech, Inc.
Epic Sciences
Fluxion Biosciences, Inc.
Greiner Bio-One International GmbH
Ikonisys, Inc.
IVDiagnostics, Inc.
LineaRx, Inc. (Vitatex, Inc.)
LungLife AI, Inc.
Menarini Silicon Biosystems
Miltenyi Biotec
Precision for Medicine
QIAGEN
Rarecells Diagnostics
ScreenCell
STEMCELL Technologies, Inc.
Sysmex Corporation
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Circulating Tumor Cells Market Overview and Key Findings, 2024
1.2 Circulating Tumor Cells Market Size and Growth Outlook, 2021- 2030
1.3 Circulating Tumor Cells Market Growth Opportunities to 2030
1.4 Key Circulating Tumor Cells Market Trends and Challenges
1.4.1 Circulating Tumor Cells Market Drivers and Trends
1.4.2 Circulating Tumor Cells Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Circulating Tumor Cells Companies
2. CIRCULATING TUMOR CELLS MARKET SIZE OUTLOOK TO 2030
2.1 Circulating Tumor Cells Market Size Outlook, USD Million, 2021- 2030
2.2 Circulating Tumor Cells Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CIRCULATING TUMOR CELLS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CIRCULATING TUMOR CELLS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Technology
CTC Detection & Enrichment Methods
-Immunocapture (Label-based)
-Size-based Separation (Label-free)
-Density-based Separation (Label-free)
-Combined Methods
CTC Direct Detection Methods
-SERS
-Microscopy
-Others
CTC Analysis
By Application
Clinical/ Liquid Biopsy
-Risk Assessment
-Screening and Monitoring
Research
-Cancer Stem Cell & Tumorogenesis Research
-Drug/Therapy Development
By Product
Kits & Reagents
Blood Collection Tubes
Devices or Systems
By Specimen
Blood
Bone Marrow
Others
By End-user
Research and Academic Institutes
Hospital and Clinics
Diagnostic Centers
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Circulating Tumor Cells Market, 2025
5.2 Asia Pacific Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Circulating Tumor Cells Market, 2025
5.5 Europe Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.6 Europe Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Circulating Tumor Cells Market, 2025
5.8 North America Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.9 North America Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Circulating Tumor Cells Market, 2025
5.11 South America Pacific Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.12 South America Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Circulating Tumor Cells Market, 2025
5.14 Middle East Africa Circulating Tumor Cells Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Circulating Tumor Cells Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Circulating Tumor Cells Market Size Outlook and Revenue Growth Forecasts
6.2 US Circulating Tumor Cells Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Circulating Tumor Cells Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Circulating Tumor Cells Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Circulating Tumor Cells Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Circulating Tumor Cells Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Circulating Tumor Cells Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Circulating Tumor Cells Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Circulating Tumor Cells Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Circulating Tumor Cells Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Circulating Tumor Cells Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Circulating Tumor Cells Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Circulating Tumor Cells Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Circulating Tumor Cells Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Circulating Tumor Cells Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Circulating Tumor Cells Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Circulating Tumor Cells Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Circulating Tumor Cells Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Circulating Tumor Cells Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Circulating Tumor Cells Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Circulating Tumor Cells Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Circulating Tumor Cells Industry Drivers and Opportunities
7. CIRCULATING TUMOR CELLS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CIRCULATING TUMOR CELLS COMPANY PROFILES
8.1 Profiles of Leading Circulating Tumor Cells Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AVIVA Biosciences
BIOCEPT, Inc.
BioCEP Ltd.
BioFluidica
Biolidics Limited
Bio-Techne Corporation
Canopus Bioscience Ltd.
Creativ MicroTech, Inc.
Epic Sciences
Fluxion Biosciences, Inc.
Greiner Bio-One International GmbH
Ikonisys, Inc.
IVDiagnostics, Inc.
LineaRx, Inc. (Vitatex, Inc.)
LungLife AI, Inc.
Menarini Silicon Biosystems
Miltenyi Biotec
Precision for Medicine
QIAGEN
Rarecells Diagnostics
ScreenCell
STEMCELL Technologies, Inc.
Sysmex Corporation
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
